Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy.

Saved in:
Bibliographic Details
Title: Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy.
Authors: Nassif ME; University of Missouri Kansas City Healthcare Institute for Innovations in Quality, and Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA. Electronic address: mnassif@saint-lukes.org., Garcia-Pavia P; Hospital Universitario Puerta de Hierro de Majadahonda, Instituto Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, and Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain., Masri A; Hypertrophic Cardiomyopathy Center, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, USA., Merkely B; Heart and Vascular Center, Semmelweis University, Budapest, Hungary., Peña-Peña ML; General Hospital of H.U. Virgen del Rocio, Seville, Spain., Barriales-Villa R; Complexo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica de A Coruña, CIBERCV-Instituto de Salud Carlos III, A Coruña, Spain., Bilen O; Emory University Medical Center, Atlanta, Georgia, USA., Burroughs M; Wellstar Center for Cardiovascular Care, Hiram, Georgia, USA., Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Costabel JP; Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina., de Barros Correia E; Dante Pazzanese Institute of Cardiology, São Paulo, Brazil., Dybro AM; Aarhus Hospital University, Aarhus, Denmark., Elliott P; Department of Inherited Cardiovascular Diseases, St. Bartholomew's Hospital, Institute of Cardiovascular Science, University College London, London, United Kingdom., Lakdawala NK; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Lewis GD; Division of Cardiology, Department of Medicine, Massachusetts General Hospital, and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Mann A; Colorado Springs, Colorado, USA., Maron MS; Lahey Hospital and Medical Center, Burlington, Massachusetts, USA., Miao ZM; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Nair A; Texas Heart Institute at Baylor College of Medicine, Houston, Texas, USA., Poulsen SH; Aarhus Hospital University, Aarhus, Denmark., Reant P; University Hospital Center of Bordeaux, Centre d'Investigation Clinique Plurithématique 1401, University of Bordeaux, Bordeaux, France., Schulze PC; University Hospital Jena, Friedrich-Schiller-University, Jena, Germany., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Wang A; Duke University Medical Center, Durham, North Carolina, USA., Sohn R; Cytokinetics, South San Francisco, California, USA., Berhane I; Cytokinetics, South San Francisco, California, USA., Heitner SB; Cytokinetics, South San Francisco, California, USA., Jacoby DL; Cytokinetics, South San Francisco, California, USA., Kupfer S; Cytokinetics, South San Francisco, California, USA., Malik FI; Cytokinetics, South San Francisco, California, USA., Wohltman A; Cytokinetics, South San Francisco, California, USA., Fifer MA; Division of Cardiology, Department of Medicine, Massachusetts General Hospital, and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Spertus JA; University of Missouri Kansas City Healthcare Institute for Innovations in Quality, and Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.
Corporate Authors: MAPLE-HCM Investigators
Source: Journal of the American College of Cardiology [J Am Coll Cardiol] 2026 Mar 03; Vol. 87 (8), pp. 1046-1058. Date of Electronic Publication: 2025 Nov 18.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Comparative Study
Journal Info: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-3597
DOI:10.1016/j.jacc.2025.10.059